Drug recall · July 24, 2013
QUETIAPINE Fumarate Tablets 25mg 100 Tablets recall
Why: Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01
- Lots / codes
Lot 122600 Exp. 03/14
- Quantity
- 19060 blister cards
- Company
- American Health Packaging, Columbus, OH
- Distribution
- Nationwide
- Initiated
- October 10, 2012 · Voluntary: Firm initiated
- Classified
- July 15, 2013
- Reported
- July 24, 2013
- Ended
- August 21, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Quetiapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.